BIBLIOGRAPHIC RECORD

Mifepristone (RU-486®) as a Schedule IV Controlled Drug—Implications for a Misleading Drug Policy on Women’s Health Care

This record contains bibliographic metadata. Open the linked source to check the work; the record does not include its full text.

Recorded authors
Yi‐Ping Hsieh; Yunju Wang; Ling‐Yi Feng; Li‐Tzy Wu; Jih‐Heng Li
Source of metadata
Crossref
Year recorded
2022

Public identifiers and source

Open the source record

Reference

Yi‐Ping Hsieh; Yunju Wang; Ling‐Yi Feng; Li‐Tzy Wu; Jih‐Heng Li. (2022). Mifepristone (RU-486®) as a Schedule IV Controlled Drug—Implications for a Misleading Drug Policy on Women’s Health Care. https://doi.org/10.3390/ijerph19148363

Reference assembled from the available metadata. Check and cite the original publication before reusing a claim.

Permanent record URL: https://brain.psiconautica.org/en/documentos/d-0ad4c4ba5d4a409cf958dbb3849a98e2/